Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Penwest Pharmaceuticals Co.

Home Clinical Trial Sponsors and OrganizationsPenwest Pharmaceuticals Co.

Penwest Pharmaceuticals Co.

ACTIVE

纽约州普特南县, New York, United StatesPrivate39 employeesEstablished: 1991-01-01

Part of Endo Health Solutions, Inc.

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

3

1 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

1991

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 2

2

66.7%

Trial Status Distribution

Active, not recruiting

1

33.3%

Completed

1

33.3%

Terminated

1

33.3%

Clinical Trials

Trials sponsored by this organization (3)

Safety and Efficacy Study of A0001 in Patients With the A3243G Mitochondrial DNA Point Mutation

Feb 201030 participants

Safety and Efficacy Study of A0001 in Subjects With Friedreich's Ataxia

Dec 200942 participants

A Phase 2a, Double Blind, Randomized, Placebo-controlled, 28 day, Two-arm, Parallel Group Study of A0001 in Patients with the A3243G Mitochondrial DNA Point Mutation and Evidence of Impaired Mitochondrial Function - MEL01. A0001 in Patients with A3243G Mitochondrial DNA Mutatio

Active, not recruiting

Sep 200930 participants

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials3
Approvals
News

Back to Organizations